| Utestående aktier | 78,055,846 shares |
| Insideraktier | 43 376 134 shares |
| Insynsägande | 55,57 % |
| Totalt antal insynspersoner | 43 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-0.018 %( )
10105 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Replimune Group, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Atlas Venture Associates X, L.p.
10% Owner -
|
4 453 386 | 4 453 386 | |
| Philip Astley-Sparke Director - [D] | 1 405 071 | 1 405 071 | |
| Atlas Venture Associates Opportunity I, L.P. - | 2 200 000 | 2 200 000 | |
| Atlas Venture Associates Opportunity I, LLC - | 2 200 000 | 2 200 000 | |
|
Atlas Venture Associates X, LLC
10% Owner -
|
4 453 386 | 4 453 386 | |
|
Atlas Venture Fund X, L.P.
10% Owner -
|
2 486 296 | 2 486 296 | |
| Atlas Venture Opportunity Fund I, L.P. - | 2 200 000 | 2 200 000 | |
|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
10 116 095 | 10 116 095 | |
|
BCIP Life Sciences Associates, LP
10% Owner -
|
2 838 968 | 2 838 968 | |
|
Bain Capital Life Sciences Fund, L.P.
10% Owner -
|
2 838 968 | 2 838 968 | |
|
Bain Capital Life Sciences Investors, LLC
10% Owner -
|
2 838 968 | 2 838 968 | |
|
Bain Capital Life Sciences Partners, LP
10% Owner -
|
2 838 968 | 2 838 968 | |
| Robert Coffin Director - [D] | 1 821 872 | 1 821 872 | |
| Kapil Dhingra Director - [D] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Pamela Esposito Chief Business Officer - [O] | 263 436 | 263 436 | |
|
Forbion Capital Fund III Cooperatief U.A.
10% Owner -
|
4 721 449 | 4 721 449 | |
| Franchi Jean M. Chief Financial Officer - [O] | 128 748 | 128 748 | |
| Stephen A Gorgol | 66 050 | ||
|
Jeremy Green
10% Owner -
|
779 655 | 779 655 | |
| Emily Luisa Hill Chief Financial Officer - [O] | 134 368 | 134 368 | |
| Howard Kaufman Chief Medical Officer - [O] | 58 067 | 58 067 | |
|
Adam Koppel
10% Owner -
|
2 838 968 | 2 838 968 | |
| Hyam Levitsky | 16 500 | ||
| Tanya Lewis Chief Dev. Op. Officer - [O] | 135 293 | 135 293 | |
|
Lim Richard J.
10% Owner -
|
13 500 | 4 854 783 | |
| Colin Love Chief Operating Officer - [O] | 777 345 | 777 345 | |
| Oliger Christy J. | 16 500 | ||
|
Omega Fund IV G.P. Manager, Ltd.
10% Owner -
|
4 763 380 | 4 673 380 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Omega Fund IV GP, L.P.
10% Owner -
|
4 763 380 | 4 673 380 | |
|
Omega Fund IV, L.P.
10% Owner -
|
4 673 380 | 4 673 380 | |
| Sushil Patel Chief Executive Officer, Director - [D] [O] | 343 576 | 343 576 | |
| Andrea Pirzkall Chief Medical Officer - [O] | 21 500 | 21 500 | |
| Paolo Pucci | 16 500 | ||
|
Redmile Group, LLC
10% Owner -
|
779 655 | 779 655 | |
| Jason P Rhodes Director - [D] | 946 000 | 946 000 | |
| Joseph P Slattery Director - [D] | 6 667 | 6 667 | |
| Christopher Sarchi Chief Commercial Officer - [O] | 128 296 | 128 296 | |
|
Jeffrey Lawrence Schwartz
10% Owner -
|
2 838 968 | 2 838 968 | |
| Andrew Schwendenman Chief Accounting Officer - [O] | 68 284 | 68 284 | |
|
Hugo Alexander Slootweg
Director, 10% Owner -
[D]
|
4 721 449 | 4 721 449 | |
|
Otello Stampacchia
Director, 10% Owner -
[D]
|
16 500 | 4 673 380 | |
| Dieter Weinand | 24 750 | ||
| Konstantinos Xynos Chief Medical Officer - [O] | 146 933 | 146 933 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i REPL / Replimune Group, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i REPL / Replimune Group, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-19 | 2025-08-15 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 5,3700 | −9 154 | −49 | 134 368 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 8,0600 | −32 279 | −260 | 1 405 071 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 8,0600 | −7 952 | −64 | 146 933 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Patel Sushil | REPL | Common Stock | D | 8,0600 | −25 105 | −202 | 343 576 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Schwendenman Andrew | REPL | Common Stock | D | 8,0500 | −3 287 | −26 | 68 284 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 8,0500 | −2 535 | −20 | 143 522 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Sarchi Christopher | REPL | Common Stock | D | 8,0500 | −3 749 | −30 | 128 296 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Patel Sushil | REPL | Common Stock | D | 166 667 | 368 681 | ||||||
| 2025-04-03 | 2025-04-01 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 45 000 | 154 885 | ||||||
| 2025-04-03 | 2025-04-01 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 45 000 | 146 057 | ||||||
| 2025-04-03 | 2025-04-01 | 4 | Sarchi Christopher | REPL | Common Stock | D | 45 000 | 132 045 | ||||||
| 2025-04-03 | 2025-04-01 | 4 | Schwendenman Andrew | REPL | Common Stock | D | −33 333 | 71 571 | ||||||
| 2025-03-07 | 3 | BAKER BROS. ADVISORS LP See Footnotes | REPL | Common Stock | I | 10 116 095 | ||||||||
| 2025-03-07 | 3 | BAKER BROS. ADVISORS LP See Footnotes | REPL | Common Stock | I | 929 241 | ||||||||
| 2024-12-18 | 2024-12-16 | 4 | Patel Sushil | REPL | Common Stock | D | 12,4200 | −10 000 | −124 | 202 014 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 10,7800 | −7 246 | −78 | 109 885 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Sarchi Christopher | REPL | Common Stock | D | 10,7800 | −5 207 | −56 | 87 045 | ||||
| 2024-08-30 | 2024-08-30 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | −50 000 | 1 437 350 | ||||||
| 2024-08-19 | 2024-08-16 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 10,1800 | −8 938 | −91 | 101 057 | ||||
| 2024-06-10 | 2024-06-07 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 7,5000 | −15 881 | −119 | 117 131 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Sarchi Christopher | REPL | Common Stock | D | 6,4700 | −2 218 | −14 | 92 252 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Schwendenman Andrew | REPL | Common Stock | D | 6,4700 | −2 298 | −15 | 38 238 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Love Colin | REPL | Common Stock | D | 6,4700 | −17 615 | −114 | 777 345 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 6,4700 | −37 928 | −245 | 1 487 350 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Coffin Robert | REPL | Common Stock | D | 6,4700 | −11 464 | −74 | 1 821 872 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Patel Sushil | REPL | Common Stock | D | 6,4700 | −20 194 | −131 | 212 014 | ||||
| 2024-05-20 | 2024-05-16 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 6,4700 | −6 367 | −41 | 133 012 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Patel Sushil | REPL | Common Stock | D | 83 335 | 232 208 | ||||||
| 2024-04-03 | 2024-04-01 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 26 665 | 139 379 | ||||||
| 2024-04-03 | 2024-04-01 | 4 | Schwendenman Andrew | REPL | Common Stock | D | 17 775 | 40 536 | ||||||
| 2024-04-03 | 2024-04-01 | 4 | Sarchi Christopher | REPL | Common Stock | D | 22 225 | 94 470 | ||||||
| 2024-04-03 | 2024-04-01 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 26 665 | 109 995 | ||||||
| 2023-11-17 | 2023-11-16 | 4 | Sarchi Christopher | REPL | Common Stock | D | 10,9200 | −5 255 | −57 | 72 245 | ||||
| 2023-11-17 | 2023-11-16 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 10,9200 | −7 313 | −80 | 112 714 | ||||
| 2023-09-20 | 2023-09-18 | 4 | Hill Emily Luisa | REPL | Common Stock | D | 83 330 | 83 330 | ||||||
| 2023-09-13 | 2023-09-12 | 4 | Esposito Pamela | REPL | Common Stock | D | 20,0000 | −300 | −6 | 263 436 | ||||
| 2023-09-13 | 2023-09-12 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 300 | 1 | 263 736 | ||||
| 2023-09-13 | 2023-09-11 | 4 | Esposito Pamela | REPL | Common Stock | D | 20,0100 | −5 358 | −107 | 263 436 | ||||
| 2023-09-13 | 2023-09-11 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 5 358 | 18 | 268 794 | ||||
| 2023-08-24 | 2023-08-22 | 4 | Esposito Pamela | REPL | Common Stock | D | 20,0100 | −18 600 | −372 | 263 436 | ||||
| 2023-08-24 | 2023-08-22 | 4 | Esposito Pamela | REPL | Common Stock | D | 15,5000 | 5 000 | 78 | 282 036 | ||||
| 2023-08-24 | 2023-08-22 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 13 600 | 45 | 277 036 | ||||
| 2023-08-15 | 2023-08-11 | 4 | Esposito Pamela | REPL | Common Stock | D | 20,0000 | −1 400 | −28 | 263 436 | ||||
| 2023-08-15 | 2023-08-11 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 1 400 | 5 | 264 836 | ||||
| 2023-07-26 | 3 | Sarchi Christopher | REPL | Common Stock | D | 55 000 | ||||||||
| 2023-07-26 | 3 | Sarchi Christopher | REPL | Common Stock | D | 22 500 | ||||||||
| 2023-07-11 | 2023-07-10 | 4 | Esposito Pamela | REPL | Common Stock | D | 21,1200 | −2 077 | −44 | 263 436 | ||||
| 2023-07-11 | 2023-07-10 | 4 | Esposito Pamela | REPL | Common Stock | D | 21,6300 | −17 923 | −388 | 265 513 | ||||
| 2023-07-11 | 2023-07-10 | 4 | Esposito Pamela | REPL | Common Stock | D | 15,5000 | 5 000 | 78 | 283 436 | ||||
| 2023-07-11 | 2023-07-10 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 15 000 | 50 | 278 436 | ||||
| 2023-06-15 | 2023-06-13 | 4 | Lewis Tanya | REPL | Common Stock | D | 23,4500 | −817 | −19 | 135 293 | ||||
| 2023-06-15 | 2023-06-13 | 4 | Lewis Tanya | REPL | Common Stock | D | 24,1000 | −12 043 | −290 | 136 110 | ||||
| 2023-06-15 | 2023-06-13 | 4 | Patel Sushil | REPL | Common Stock | D | 23,4400 | −553 | −13 | 148 873 | ||||
| 2023-06-15 | 2023-06-13 | 4 | Patel Sushil | REPL | Common Stock | D | 24,1100 | −5 145 | −124 | 149 426 | ||||
| 2023-05-18 | 3 | Schwendenman Andrew | REPL | Common Stock | D | 22 761 | ||||||||
| 2023-05-18 | 2023-05-16 | 4 | Coffin Robert | REPL | Common Stock | D | 18,0500 | −7 861 | −142 | 1 833 336 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Patel Sushil | REPL | Common Stock | D | 18,0500 | −15 575 | −281 | 154 571 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Lewis Tanya | REPL | Common Stock | D | 18,0500 | −12 207 | −220 | 148 153 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Franchi Jean M. | REPL | Common Stock | D | 18,0500 | −11 351 | −205 | 128 748 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Love Colin | REPL | Common Stock | D | 18,0500 | −10 775 | −194 | 794 960 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 18,0500 | −771 | −14 | 120 027 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Esposito Pamela | REPL | Common Stock | D | 18,0500 | −5 966 | −108 | 263 436 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 18,0500 | −17 902 | −323 | 1 525 278 | ||||
| 2023-04-04 | 2023-04-01 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 50 000 | 120 798 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Esposito Pamela | REPL | Common Stock | D | 40 000 | 269 402 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Coffin Robert | REPL | Common Stock | D | 45 000 | 1 841 197 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Lewis Tanya | REPL | Common Stock | D | 40 000 | 160 360 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Patel Sushil | REPL | Common Stock | D | 40 000 | 170 146 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 142 100 | 1 543 180 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Love Colin | REPL | Common Stock | D | 40 000 | 805 735 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Franchi Jean M. | REPL | Common Stock | D | 45 000 | 140 099 | ||||||
| 2022-12-13 | 2022-12-09 | 4 | Esposito Pamela | REPL | Common Stock | D | 25,0300 | −15 000 | −375 | 229 402 | ||||
| 2022-12-13 | 2022-12-09 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 15 000 | 15 | 244 402 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Xynos Konstantinos | REPL | Common Stock | D | 17 500 | 70 798 | ||||||
| 2022-12-05 | 3 | Xynos Konstantinos | REPL | Common Stock | D | 8 798 | ||||||||
| 2022-12-05 | 3 | Xynos Konstantinos | REPL | Common Stock | D | 7 000 | ||||||||
| 2022-12-05 | 3 | Xynos Konstantinos | REPL | Common Stock | D | 37 500 | ||||||||
| 2022-05-18 | 2022-05-16 | 4 | Love Colin | REPL | Common Stock | D | 14,5900 | −6 324 | −92 | 765 735 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Franchi Jean M. | REPL | Common Stock | D | 14,5900 | −3 436 | −50 | 95 099 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Esposito Pamela | REPL | Common Stock | D | 14,5900 | −3 507 | −51 | 229 402 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Lewis Tanya | REPL | Common Stock | D | 14,5900 | −5 473 | −80 | 120 360 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Patel Sushil | REPL | Common Stock | D | 14,5900 | −10 687 | −156 | 130 146 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Coffin Robert | REPL | Common Stock | D | 14,5900 | −5 737 | −84 | 1 796 197 | ||||
| 2022-05-18 | 2022-05-16 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 14,5900 | −9 632 | −141 | 1 401 080 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Coffin Robert | REPL | Employee Stock Option (right to buy) | D | 18,26 | 39 375 | 39 375 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Coffin Robert | REPL | Common Stock | D | 26 250 | 1 801 934 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 18,26 | 78 750 | 78 750 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Franchi Jean M. | REPL | Common Stock | D | 52 500 | 98 535 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Astley-Sparke Philip | REPL | Employee Stock Option (right to buy) | D | 18,26 | 105 000 | 105 000 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 70 000 | 1 410 712 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Patel Sushil | REPL | Employee Stock Option (right to buy) | D | 18,26 | 78 750 | 78 750 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Patel Sushil | REPL | Common Stock | D | 52 500 | 140 833 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Lewis Tanya | REPL | Employee Stock Option (right to buy) | D | 18,26 | 78 750 | 78 750 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Lewis Tanya | REPL | Common Stock | D | 52 500 | 125 833 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 18,26 | 34 125 | 34 125 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Esposito Pamela | REPL | Common Stock | D | 22 750 | 232 909 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Rhodes Jason P | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Love Colin | REPL | Employee Stock Option (right to buy) | D | 18,26 | 39 375 | 39 375 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Love Colin | REPL | Common Stock | D | 26 250 | 772 059 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Slootweg Hugo Alexander | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Weinand Dieter | REPL | Stock Option (right to buy) | D | 18,26 | 24 750 | 24 750 | |||||
| 2022-04-05 | 2022-04-01 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Pucci Paolo | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Oliger Christy J. | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Levitsky Hyam | REPL | Stock Option (right to buy) | D | 18,26 | 16 500 | 16 500 | |||||
| 2022-03-16 | 2022-03-16 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 15,5500 | −38 762 | −603 | 4 673 380 | ||||
| 2022-03-16 | 2022-03-16 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 15,3100 | −6 238 | −96 | 4 712 142 | ||||
| 2022-03-16 | 2022-03-15 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 15,6400 | −45 000 | −704 | 4 718 380 | ||||
| 2022-03-16 | 2022-03-14 | 4 | Omega Fund IV, L.P. By Otello Stampacchia | REPL | Non-Qualified Stock Options | I | 9,78 | −16 500 | 16 500 | |||||
| 2022-03-16 | 2022-03-14 | 4 | Omega Fund IV, L.P. By Otello Stampacchia | REPL | Common Stock | I | 15,4200 | −16 500 | −254 | 4 763 380 | ||||
| 2022-03-16 | 2022-03-14 | 4 | Omega Fund IV, L.P. By Otello Stampacchia | REPL | Common Stock | I | 9,7800 | 16 500 | 161 | 4 779 880 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Oliger Christy J. | REPL | Stock Option (right to buy) | D | 28,01 | 33 000 | 33 000 | |||||
| 2021-11-23 | 2021-11-22 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 34,7000 | −10 162 | −353 | 4 763 380 | ||||
| 2021-11-23 | 2021-11-19 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 34,8000 | −417 | −15 | 4 773 542 | ||||
| 2021-11-23 | 2021-11-19 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 34,5400 | −34 845 | −1 204 | 4 773 959 | ||||
| 2021-11-18 | 2021-11-18 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −2 441 | −82 | 4 808 804 | ||||
| 2021-11-18 | 2021-11-16 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −153 | −5 | 4 811 245 | ||||
| 2021-11-18 | 2021-11-18 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −2 441 | −82 | 4 808 804 | ||||
| 2021-11-18 | 2021-11-16 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −153 | −5 | 4 811 245 | ||||
| 2021-11-16 | 2021-11-15 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,6600 | −782 | −26 | 4 811 398 | ||||
| 2021-11-16 | 2021-11-12 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,6600 | −23 235 | −782 | 4 812 180 | ||||
| 2021-11-12 | 2021-11-11 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,6100 | −18 279 | −614 | 4 835 415 | ||||
| 2021-11-12 | 2021-11-10 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −11 | −0 | 4 853 694 | ||||
| 2021-11-10 | 2021-11-09 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,7300 | −7 537 | −254 | 4 853 705 | ||||
| 2021-11-10 | 2021-11-08 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5300 | −3 817 | −128 | 4 861 242 | ||||
| 2021-11-08 | 2021-11-05 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5000 | −5 790 | −194 | 4 865 059 | ||||
| 2021-11-08 | 2021-11-04 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5800 | −25 225 | −847 | 4 870 849 | ||||
| 2021-10-19 | 2021-10-18 | 4 | Love Colin | REPL | Common Stock | D | 29,5800 | −12 711 | −376 | 745 809 | ||||
| 2021-10-19 | 2021-10-15 | 4 | Love Colin | REPL | Common Stock | D | 30,3100 | −15 089 | −457 | 758 520 | ||||
| 2021-10-19 | 2021-10-15 | 4 | Love Colin | REPL | Common Stock | D | 31,1600 | −2 200 | −69 | 773 609 | ||||
| 2021-09-27 | 2021-09-23 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,5800 | −12 171 | −409 | 4 896 074 | ||||
| 2021-09-20 | 2021-09-17 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 33,7100 | −15 465 | −521 | 4 908 245 | ||||
| 2021-09-20 | 2021-09-17 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 32,8800 | −78 998 | −2 597 | 4 923 710 | ||||
| 2021-09-20 | 2021-09-16 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 32,5500 | −5 537 | −180 | 5 002 708 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Love Colin | REPL | Common Stock | D | 31,2300 | −30 000 | −937 | 775 809 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Love Colin | REPL | Common Stock | D | 29,2700 | −2 700 | −79 | 805 809 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Love Colin | REPL | Common Stock | D | 30,0000 | −27 300 | −819 | 808 509 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 15,50 | −25 800 | 45 750 | |||||
| 2021-08-06 | 2021-08-05 | 4 | Esposito Pamela | REPL | Common Stock | D | 35,0900 | −25 800 | −905 | 210 159 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Esposito Pamela | REPL | Common Stock | D | 15,5000 | 25 800 | 400 | 235 959 | ||||
| 2021-08-06 | 2021-08-04 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 15,50 | −4 200 | 71 550 | |||||
| 2021-08-06 | 2021-08-04 | 4 | Esposito Pamela | REPL | Common Stock | D | 35,0000 | −4 200 | −147 | 210 159 | ||||
| 2021-08-06 | 2021-08-04 | 4 | Esposito Pamela | REPL | Common Stock | D | 15,5000 | 4 200 | 65 | 214 359 | ||||
| 2021-07-22 | 2021-07-21 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −12 538 | 51 203 | |||||
| 2021-07-22 | 2021-07-21 | 4 | Esposito Pamela | REPL | Common Stock | D | 33,1700 | −12 538 | −416 | 210 159 | ||||
| 2021-07-22 | 2021-07-21 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 12 538 | 13 | 222 697 | ||||
| 2021-07-22 | 2021-07-20 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −4 862 | 63 741 | |||||
| 2021-07-22 | 2021-07-20 | 4 | Esposito Pamela | REPL | Common Stock | D | 33,0500 | −4 862 | −161 | 210 159 | ||||
| 2021-07-22 | 2021-07-20 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 4 862 | 5 | 215 021 | ||||
| 2021-07-19 | 2021-01-19 | 4/A | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −5 727 | 73 203 | |||||
| 2021-07-19 | 2021-01-19 | 4/A | Esposito Pamela | REPL | Common Stock | D | 42,3800 | −5 127 | −217 | 175 994 | ||||
| 2021-07-19 | 2021-01-19 | 4/A | Esposito Pamela | REPL | Common Stock | D | 43,2400 | −600 | −26 | 181 121 | ||||
| 2021-07-19 | 2021-01-19 | 4/A | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 5 727 | 6 | 181 721 | ||||
| 2021-07-19 | 2021-01-15 | 4/A | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −29 273 | 78 930 | |||||
| 2021-07-19 | 2021-01-15 | 4/A | Esposito Pamela | REPL | Common Stock | D | 43,5800 | −29 273 | −1 276 | 175 994 | ||||
| 2021-07-19 | 2021-01-15 | 4/A | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 29 273 | 30 | 205 267 | ||||
| 2021-07-19 | 2021-01-14 | 4/A | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −20 000 | 108 203 | |||||
| 2021-07-19 | 2021-01-14 | 4/A | Esposito Pamela | REPL | Common Stock | D | 45,0200 | −20 000 | −900 | 175 994 | ||||
| 2021-07-19 | 2021-01-14 | 4/A | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 20 000 | 20 | 195 994 | ||||
| 2021-07-19 | 2021-07-15 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −4 600 | 68 603 | |||||
| 2021-07-19 | 2021-07-15 | 4 | Esposito Pamela | REPL | Common Stock | D | 33,3700 | −4 600 | −154 | 210 159 | ||||
| 2021-07-19 | 2021-07-15 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 4 600 | 5 | 214 759 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Love Colin | REPL | Common Stock | D | 32,0200 | −30 000 | −961 | 835 809 | ||||
| 2021-07-07 | 2021-07-02 | 4 | Coffin Robert | REPL | Common Stock | D | 40,0400 | −7 810 | −313 | 1 775 684 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Coffin Robert | REPL | Common Stock | D | 40,0500 | −22 826 | −914 | 1 783 494 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Coffin Robert | REPL | Common Stock | D | 40,0400 | −14 663 | −587 | 1 806 320 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Love Colin | REPL | Common Stock | D | 34,5300 | −12 200 | −421 | 865 809 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Love Colin | REPL | Common Stock | D | 33,8000 | −17 800 | −602 | 878 009 | ||||
| 2021-05-11 | 2021-05-10 | 4 | Lewis Tanya | REPL | Employee Stock Option (right to buy) | D | 33,99 | 110 000 | 110 000 | |||||
| 2021-05-11 | 2021-05-10 | 4 | Lewis Tanya | REPL | Common Stock | D | 73 333 | 73 333 | ||||||
| 2021-05-05 | 2021-05-03 | 4 | Patel Sushil | REPL | Employee Stock Option (right to buy) | D | 36,75 | 125 000 | 125 000 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Patel Sushil | REPL | Common Stock | D | 88 333 | 88 333 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | Love Colin | REPL | Common Stock | D | 29,9800 | −2 700 | −81 | 895 809 | ||||
| 2021-04-19 | 2021-04-15 | 4 | Love Colin | REPL | Common Stock | D | 30,6900 | −27 300 | −838 | 898 509 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 31,58 | 51 250 | 51 250 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Esposito Pamela | REPL | Common Stock | D | 34 165 | 210 159 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 31,58 | 69 050 | 69 050 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Franchi Jean M. | REPL | Common Stock | D | 46 035 | 46 035 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Pirzkall Andrea | REPL | Employee Stock Option (right to buy) | D | 31,58 | 30 750 | 30 750 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Pirzkall Andrea | REPL | Common Stock | D | 20 500 | 21 500 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Astley-Sparke Philip | REPL | Employee Stock Option (right to buy) | D | 31,58 | 128 125 | 128 125 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 85 415 | 1 340 712 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Coffin Robert | REPL | Employee Stock Option (right to buy) | D | 31,58 | 115 300 | 115 300 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Coffin Robert | REPL | Common Stock | D | 76 865 | 1 820 983 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Rhodes Jason P | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Love Colin | REPL | Employee Stock Option (right to buy) | D | 31,58 | 58 925 | 58 925 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Love Colin | REPL | Common Stock | D | 39 285 | 925 809 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Levitsky Hyam | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Lewis Tanya | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Pucci Paolo | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Slootweg Hugo Alexander | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Weinand Dieter | REPL | Stock Option (right to buy) | D | 31,58 | 24 750 | 24 750 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Omega Fund IV, L.P. | REPL | Stock Option (Right to Buy) | D | 31,58 | 16 500 | 16 500 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Love Colin | REPL | Common Stock | D | 32,6700 | −100 | −3 | 886 524 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Love Colin | REPL | Common Stock | D | 33,2200 | −18 518 | −615 | 886 624 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Love Colin | REPL | Common Stock | D | 34,0600 | −11 382 | −388 | 905 142 | ||||
| 2021-02-18 | 2021-02-16 | 4 | Love Colin | REPL | Common Stock | D | 35,8400 | −11 380 | −408 | 916 524 | ||||
| 2021-02-18 | 2021-02-16 | 4 | Love Colin | REPL | Common Stock | D | 36,6100 | −18 620 | −682 | 927 904 | ||||
| 2021-02-11 | 2021-02-08 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,0000 | −5 249 | −236 | 5 141 321 | ||||
| 2021-01-28 | 2021-01-26 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,1400 | −5 558 | −256 | 946 000 | ||||
| 2021-01-28 | 2021-01-26 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 46,0400 | −3 393 | −156 | 5 283 682 | ||||
| 2021-01-28 | 2021-01-26 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,3400 | −26 957 | −1 222 | 5 287 075 | ||||
| 2021-01-26 | 2021-01-22 | 4 | Coffin Robert | REPL | Common Stock | D | 43,9900 | −29 803 | −1 311 | 1 744 118 | ||||
| 2021-01-26 | 2021-01-22 | 4 | Coffin Robert | REPL | Common Stock | D | 44,8700 | −30 197 | −1 355 | 1 773 921 | ||||
| 2021-01-26 | 2021-01-22 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,0300 | −3 269 | −147 | 5 314 032 | ||||
| 2021-01-26 | 2021-01-22 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,0500 | −8 090 | −364 | 5 317 301 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 42,4000 | −7 632 | −324 | 1 255 297 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,1500 | −800 | −35 | 1 262 929 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,0200 | −9 409 | −405 | 1 263 729 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,7100 | −6 059 | −265 | 1 273 138 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 44,9500 | −1 100 | −49 | 1 279 197 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,0600 | −100 | −4 | 1 280 297 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,6100 | −7 448 | −325 | 1 280 397 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 44,7800 | −17 452 | −782 | 1 287 845 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −5 727 | 73 203 | |||||
| 2021-01-19 | 2021-01-19 | 4 | Esposito Pamela | REPL | Common Stock | D | 42,3800 | −5 127 | −217 | 175 994 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Esposito Pamela | REPL | Common Stock | D | 43,2400 | −600 | −26 | 181 121 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 5 727 | 6 | 181 721 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −29 273 | 78 930 | |||||
| 2021-01-19 | 2021-01-15 | 4 | Esposito Pamela | REPL | Common Stock | D | 43,5800 | −29 273 | −1 276 | 175 994 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 29 273 | 30 | 205 267 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −20 000 | 108 203 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Esposito Pamela | REPL | Common Stock | D | 45,0200 | −20 000 | −900 | 175 994 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 20 000 | 20 | 195 994 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Love Colin | REPL | Common Stock | D | 42,3800 | −7 157 | −303 | 946 524 | ||||
| 2021-01-19 | 2021-01-19 | 4 | Love Colin | REPL | Common Stock | D | 43,2500 | −700 | −30 | 953 681 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Love Colin | REPL | Common Stock | D | 43,0700 | −12 396 | −534 | 954 381 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Love Colin | REPL | Common Stock | D | 43,8000 | −7 547 | −331 | 966 777 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Love Colin | REPL | Common Stock | D | 45,0100 | −2 200 | −99 | 974 324 | ||||
| 2021-01-19 | 2021-01-15 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,1900 | −1 916 | −87 | 5 325 391 | ||||
| 2021-01-19 | 2021-01-14 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 45,0900 | −17 664 | −796 | 5 327 307 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 14,08 | −14 900 | 140 000 | |||||
| 2021-01-15 | 2021-01-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 44,0000 | −600 | −26 | 0 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 44,5500 | −14 300 | −637 | 600 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 14,0800 | 14 900 | 210 | 14 900 | ||||
| 2021-01-15 | 2021-01-13 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 14,08 | −100 | 154 900 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Franchi Jean M. | REPL | Common Stock | D | 44,1900 | −100 | −4 | 0 | ||||
| 2021-01-15 | 2021-01-13 | 4 | Franchi Jean M. | REPL | Common Stock | D | 14,0800 | 100 | 1 | 100 | ||||
| 2020-12-28 | 2020-12-22 | 4 | Coffin Robert | REPL | Common Stock | D | 40,0400 | −220 000 | −8 809 | 1 804 118 | ||||
| 2020-12-28 | 2020-12-23 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,75 | −50 704 | 32 758 | |||||
| 2020-12-28 | 2020-12-23 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,7500 | 50 704 | 89 | 175 994 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Rhodes Jason P | REPL | Common Stock | I | 41,9500 | −265 | −11 | 19 285 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Rhodes Jason P | REPL | Common Stock | I | 41,9500 | −1 042 | −44 | 951 558 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Rhodes Jason P | REPL | Common Stock | I | 41,9500 | −3 012 | −126 | 2 263 627 | ||||
| 2020-12-17 | 2020-12-17 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,0000 | −697 | −29 | 19 550 | ||||
| 2020-12-17 | 2020-12-17 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,0000 | −2 785 | −117 | 952 600 | ||||
| 2020-12-17 | 2020-12-17 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,0000 | −8 053 | −338 | 2 266 639 | ||||
| 2020-12-17 | 2020-12-16 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,1300 | −766 | −32 | 20 247 | ||||
| 2020-12-17 | 2020-12-16 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,1300 | −3 060 | −129 | 955 385 | ||||
| 2020-12-17 | 2020-12-16 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,1300 | −8 849 | −373 | 2 274 692 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0800 | −6 | −0 | 21 013 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,1200 | −30 | −1 | 21 019 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,4000 | −2 432 | −103 | 21 049 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0800 | −24 | −1 | 958 445 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,1200 | −120 | −5 | 958 469 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,4000 | −9 710 | −412 | 958 589 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0800 | −70 | −3 | 2 283 541 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,1200 | −349 | −15 | 2 283 611 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,4000 | −28 078 | −1 191 | 2 283 960 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 14,08 | −25 000 | 155 000 | |||||
| 2020-12-16 | 2020-12-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 42,0900 | −389 | −16 | 0 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 42,8600 | −6 755 | −290 | 389 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 43,7000 | −17 856 | −780 | 7 144 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Franchi Jean M. | REPL | Common Stock | D | 14,0800 | 25 000 | 352 | 25 000 | ||||
| 2020-12-15 | 2020-12-11 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 3,30 | −12 590 | 121 691 | |||||
| 2020-12-15 | 2020-12-11 | 4 | Esposito Pamela | REPL | Common Stock | D | 3,3000 | 12 590 | 42 | 125 290 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0600 | −181 | −8 | 23 481 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,5400 | −1 855 | −81 | 23 662 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6900 | −240 | −10 | 25 517 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0600 | −722 | −32 | 968 299 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,5400 | −7 409 | −323 | 969 021 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6900 | −961 | −41 | 976 430 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,0600 | −2 087 | −92 | 2 312 038 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,5400 | −21 428 | −933 | 2 314 125 | ||||
| 2020-12-14 | 2020-12-14 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6900 | −2 776 | −119 | 2 335 553 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,9200 | −205 | −9 | 25 757 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3200 | −1 707 | −74 | 25 962 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,9200 | −821 | −36 | 977 391 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3200 | −6 817 | −295 | 978 212 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,9200 | −2 374 | −104 | 2 338 329 | ||||
| 2020-12-14 | 2020-12-11 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3200 | −19 712 | −854 | 2 340 703 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,3500 | −230 | −10 | 27 669 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,4800 | −750 | −33 | 27 899 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6800 | −1 099 | −47 | 28 649 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,3500 | −917 | −41 | 985 029 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,4800 | −2 996 | −130 | 985 946 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6800 | −4 389 | −187 | 988 942 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,3500 | −2 653 | −118 | 2 360 415 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,4800 | −8 666 | −377 | 2 363 068 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,6800 | −12 691 | −542 | 2 371 734 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Love Colin | REPL | Common Stock | D | 41,9700 | −1 000 | −42 | 976 524 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Love Colin | REPL | Common Stock | D | 43,1000 | −13 750 | −593 | 977 524 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Love Colin | REPL | Common Stock | D | 43,9000 | −7 058 | −310 | 991 274 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Love Colin | REPL | Common Stock | D | 44,8300 | −7 492 | −336 | 998 332 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Love Colin | REPL | Common Stock | D | 45,8200 | −700 | −32 | 1 005 824 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 42,3900 | −3 863 | −164 | 1 305 297 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 42,9900 | −16 051 | −690 | 1 309 160 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,7200 | −5 086 | −222 | 1 325 211 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 42,0300 | −800 | −34 | 1 330 297 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,0900 | −11 116 | −479 | 1 331 097 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 43,8800 | −6 459 | −283 | 1 342 213 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 44,8500 | −6 025 | −270 | 1 348 672 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 45,7900 | −600 | −27 | 1 354 697 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,3200 | −151 | −7 | 29 748 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,6900 | −635 | −28 | 29 899 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3600 | −1 549 | −67 | 30 534 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,5100 | −151 | −6 | 32 083 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,4700 | −100 | −5 | 993 331 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,3200 | −604 | −27 | 993 431 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,6900 | −2 535 | −113 | 994 035 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3600 | −6 183 | −268 | 996 570 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,5100 | −603 | −26 | 1 002 753 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,3200 | −1 747 | −79 | 2 384 425 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 44,6900 | −7 330 | −328 | 2 386 172 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 43,3600 | −17 883 | −775 | 2 393 502 | ||||
| 2020-12-09 | 2020-12-09 | 4 | Rhodes Jason P | REPL | Common Stock | I | 42,5100 | −1 745 | −74 | 2 411 385 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,9400 | −2 869 | −135 | 32 234 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,0200 | −606 | −28 | 35 103 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,8900 | −45 027 | −2 111 | 1 003 356 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,1400 | −19 620 | −905 | 1 048 383 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,9400 | −33 133 | −1 555 | 2 413 130 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,0200 | −7 001 | −322 | 2 446 263 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,9100 | −106 | −5 | 35 709 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,9700 | −2 007 | −92 | 35 815 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,4600 | −748 | −34 | 37 822 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,9300 | −2 322 | −109 | 1 068 003 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,0600 | −26 713 | −1 230 | 1 070 325 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,4500 | −2 962 | −135 | 1 097 038 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 46,9100 | −1 222 | −57 | 2 453 264 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,9700 | −23 174 | −1 065 | 2 454 486 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Rhodes Jason P | REPL | Common Stock | I | 45,4600 | −8 636 | −393 | 2 477 660 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 1,75 | −40 000 | 3 169 | |||||
| 2020-12-09 | 2020-12-07 | 4 | Dhingra Kapil | REPL | Common Stock | D | 47,0400 | −1 802 | −85 | 0 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Dhingra Kapil | REPL | Common Stock | D | 46,2200 | −13 523 | −625 | 1 802 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Dhingra Kapil | REPL | Common Stock | D | 45,0900 | −24 675 | −1 113 | 15 325 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Dhingra Kapil | REPL | Common Stock | D | 1,7500 | 40 000 | 70 | 40 000 | ||||
| 2020-12-09 | 2020-12-08 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 3,30 | −5 200 | 24 640 | |||||
| 2020-12-09 | 2020-12-08 | 4 | SLATTERY JOSEPH P | REPL | Common stock | D | 46,0000 | −5 200 | −239 | 6 667 | ||||
| 2020-12-09 | 2020-12-08 | 4 | SLATTERY JOSEPH P | REPL | Common Stock | D | 3,3000 | 5 200 | 17 | 11 867 | ||||
| 2020-11-18 | 2020-11-16 | 4 | Love Colin | REPL | Common Stock | D | 44,4100 | −3 759 | −167 | 1 006 524 | ||||
| 2020-11-18 | 2020-11-16 | 4 | Love Colin | REPL | Common Stock | D | 45,0400 | −10 941 | −493 | 1 010 283 | ||||
| 2020-11-18 | 2020-11-16 | 4 | Love Colin | REPL | Common Stock | D | 46,4300 | −300 | −14 | 1 021 224 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Lewis Tanya | REPL | Stock Option (right to buy) | D | 42,00 | 33 000 | 33 000 | |||||
| 2020-10-16 | 2020-10-14 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −16 000 | 128 203 | |||||
| 2020-10-16 | 2020-10-14 | 4 | Esposito Pamela | REPL | Common Stock | D | 35,0400 | −9 000 | −315 | 112 700 | ||||
| 2020-10-16 | 2020-10-14 | 4 | Esposito Pamela | REPL | Common Stock | D | 30,1500 | −7 000 | −211 | 121 700 | ||||
| 2020-10-16 | 2020-10-14 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 16 000 | 16 | 128 700 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | −445 339 | 2 486 296 | ||||||
| 2020-09-17 | 2020-09-15 | 4 | Love Colin | REPL | Common Stock | D | 24,8300 | −1 529 | −38 | 1 021 524 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Love Colin | REPL | Common Stock | D | 24,1100 | −10 271 | −248 | 1 023 053 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Love Colin | REPL | Common Stock | D | 23,0900 | −3 200 | −74 | 1 033 324 | ||||
| 2020-09-01 | 2020-08-31 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,01 | −5 000 | 144 203 | |||||
| 2020-09-01 | 2020-08-31 | 4 | Esposito Pamela | REPL | Common Stock | D | 27,0500 | −5 000 | −135 | 112 700 | ||||
| 2020-09-01 | 2020-08-31 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,0100 | 5 000 | 5 | 117 700 | ||||
| 2020-08-18 | 2020-08-17 | 4 | Love Colin | REPL | Common Stock | D | 23,1900 | −5 964 | −138 | 1 036 524 | ||||
| 2020-08-18 | 2020-08-17 | 4 | Love Colin | REPL | Common Stock | D | 23,6000 | −9 036 | −213 | 1 042 488 | ||||
| 2020-07-22 | 3 | Pirzkall Andrea | REPL | Common Stock | I | 2 000 | ||||||||
| 2020-07-22 | 3 | Pirzkall Andrea | REPL | Common Stock | I | 2 000 | ||||||||
| 2020-07-22 | 3 | Pirzkall Andrea | REPL | Common Stock | I | 2 000 | ||||||||
| 2020-07-22 | 2020-07-20 | 4 | Pirzkall Andrea | REPL | Employee Stock Option (right to buy) | D | 22,45 | 300 000 | 300 000 | |||||
| 2020-07-10 | 2020-07-09 | 4 | Coffin Robert | REPL | Common Stock | D | 21,0200 | −24 250 | −510 | 2 024 118 | ||||
| 2020-07-10 | 2020-07-09 | 4 | Coffin Robert | REPL | Common Stock | D | 22,3200 | −145 500 | −3 248 | 2 048 368 | ||||
| 2020-07-07 | 2020-07-02 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | −445 339 | 2 931 635 | ||||||
| 2020-06-18 | 2020-06-16 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | −445 339 | 3 376 974 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | Omega Fund IV, L.P. | REPL | Stock Option (Right to Buy) | D | 9,78 | 16 500 | 16 500 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Astley-Sparke Philip | REPL | Employee Stock Option (right to buy) | D | 9,78 | 265 000 | 265 000 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Coffin Robert | REPL | Employee Stock Option (right to buy) | D | 9,78 | 265 000 | 265 000 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 9,78 | 16 500 | 16 500 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Pucci Paolo | REPL | Stock Option (right to buy) | D | 9,78 | 33 000 | 33 000 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Levitsky Hyam | REPL | Stock Option (right to buy) | D | 9,78 | 16 500 | 16 500 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Rhodes Jason P | REPL | Stock Option (right to buy) | D | 9,78 | 16 500 | 16 500 | |||||
| 2020-04-02 | 2020-04-01 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 9,78 | 24 249 | 24 249 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Slootweg Hugo Alexander | REPL | Stock Option (right to buy) | D | 9,78 | 16 500 | 16 500 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Weinand Dieter | REPL | Stock Option (right to buy) | D | 9,78 | 24 750 | 24 750 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 9,78 | 56 350 | 56 350 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Love Colin | REPL | Employee Stock Option (right to buy) | D | 9,78 | 116 550 | 116 550 | |||||
| 2020-04-02 | 2020-04-01 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 9,78 | 85 450 | 85 450 | |||||
| 2020-04-02 | 2020-04-01 | 4 | GORGOL STEPHEN A | REPL | Employee Stock Option (right to buy) | D | 9,78 | 66 050 | 66 050 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0400 | −24 250 | −413 | 2 193 868 | ||||
| 2020-02-14 | 2020-02-12 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0300 | −24 250 | −413 | 2 218 118 | ||||
| 2020-02-14 | 2020-02-12 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0400 | −24 250 | −413 | 2 242 368 | ||||
| 2019-12-23 | 2019-12-20 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,75 | −25 700 | 83 462 | |||||
| 2019-12-23 | 2019-12-20 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,7500 | 25 700 | 45 | 112 700 | ||||
| 2019-12-19 | 2019-11-26 | 4 | Kaufman Howard | REPL | Employee Stock Option (right to buy) | D | 3,30 | −58 067 | 91 135 | |||||
| 2019-12-19 | 2019-11-26 | 4 | Kaufman Howard | REPL | Common Stock | D | 3,3000 | 58 067 | 192 | 58 067 | ||||
| 2019-12-11 | 2019-12-09 | 4 | Franchi Jean M. | REPL | Employee Stock Option (right to buy) | D | 14,08 | 180 000 | 180 000 | |||||
| 2019-11-20 | 3 | Atlas Venture Associates Opportunity I, LLC | REPL | Common Stock | I | 2 200 000 | ||||||||
| 2019-11-20 | 3 | Atlas Venture Associates Opportunity I, LLC | REPL | Common Stock | I | 2 200 000 | ||||||||
| 2019-11-20 | 3 | Atlas Venture Associates Opportunity I, LLC | REPL | Common Stock | I | 2 200 000 | ||||||||
| 2019-11-20 | 3 | Atlas Venture Associates Opportunity I, LLC | REPL | Common Stock | I | 2 200 000 | ||||||||
| 2019-11-20 | 3 | Atlas Venture Associates Opportunity I, LLC | REPL | Common Stock | I | 2 200 000 | ||||||||
| 2019-11-20 | 2019-11-18 | 4 | Rhodes Jason P | REPL | Common Stock | I | 13,6100 | 1 100 000 | 14 971 | 1 100 000 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 13,6100 | 220 000 | 2 994 | 5 328 939 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0000 | −24 250 | −412 | 2 266 618 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0200 | −24 250 | −413 | 2 290 868 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0000 | −14 500 | −246 | 1 355 297 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0200 | −14 500 | −247 | 1 369 797 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Love Colin | REPL | Common Stock | D | 17,0000 | −11 250 | −191 | 1 051 524 | ||||
| 2019-11-08 | 2019-11-06 | 4 | Love Colin | REPL | Common Stock | D | 17,0200 | −11 250 | −191 | 1 062 774 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0000 | −24 250 | −412 | 2 315 118 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0520 | −24 250 | −414 | 2 339 368 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Love Colin | REPL | Common Stock | D | 17,0000 | −11 250 | −191 | 1 074 024 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Love Colin | REPL | Common Stock | D | 17,0520 | −11 250 | −192 | 1 085 274 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0000 | −14 500 | −246 | 1 384 297 | ||||
| 2019-11-06 | 2019-11-04 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0520 | −14 500 | −247 | 1 398 797 | ||||
| 2019-11-04 | 2019-10-31 | 4 | Love Colin | REPL | Common Stock | D | 17,0000 | −11 250 | −191 | 1 096 524 | ||||
| 2019-11-04 | 2019-10-31 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0000 | −14 500 | −246 | 1 413 297 | ||||
| 2019-11-04 | 2019-10-31 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0000 | −24 250 | −412 | 2 363 618 | ||||
| 2019-09-25 | 2019-09-23 | 4 | Coffin Robert | REPL | Common Stock | D | 17,0500 | −24 250 | −413 | 2 387 868 | ||||
| 2019-09-25 | 2019-09-23 | 4 | Love Colin | REPL | Common Stock | D | 17,0500 | −11 250 | −192 | 1 107 774 | ||||
| 2019-09-25 | 2019-09-23 | 4 | Astley-Sparke Philip | REPL | Common Stock | D | 17,0500 | −14 500 | −247 | 1 427 797 | ||||
| 2019-04-03 | 2019-04-01 | 4 | Omega Fund IV, L.P. | REPL | Employee Stock Option (Right to Buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | GORGOL STEPHEN A | REPL | Employee Stock Option (right to buy) | D | 15,50 | 55 000 | 55 000 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Kaufman Howard | REPL | Employee Stock Option (right to buy) | D | 15,50 | 80 500 | 80 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Love Colin | REPL | Employee Stock Option (right to buy) | D | 15,50 | 78 900 | 78 900 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Slootweg Hugo Alexander | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Rhodes Jason P | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 15,50 | 75 750 | 75 750 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Coffin Robert | REPL | Employee Stock Option (right to buy) | D | 15,50 | 219 300 | 219 300 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Astley-Sparke Philip | REPL | Employee Stock Option (right to buy) | D | 15,50 | 153 050 | 153 050 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Weinand Dieter | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Levitsky Hyam | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 15,50 | 13 500 | 13 500 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | −631 073 | 3 822 313 | ||||||
| 2018-12-17 | 2018-12-13 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 1,75 | −87 000 | 109 162 | |||||
| 2018-12-17 | 2018-12-13 | 4 | Esposito Pamela | REPL | Common Stock | D | 1,7500 | 87 000 | 152 | 87 000 | ||||
| 2018-07-26 | 2018-07-24 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | REPL | Series B Convertible Preferred Stock | I | −235 146 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Bain Capital Life Sciences Investors, LLC See Footnotes | REPL | Common Stock | I | 15,0000 | 500 000 | 7 500 | 2 838 968 | ||||
| 2018-07-26 | 2018-07-24 | 4 | Bain Capital Life Sciences Investors, LLC See Footnotes | REPL | Common Stock | I | 2 338 968 | 2 338 968 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Series B Convertible Preferred Stock | I | −1 013 547 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Series A Convertible Preferred Stock | I | −2 579 881 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Series Seed Convertible Preferred Stock | I | −994 688 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Warrant (right to buy) | I | −248 672 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Warrant (right to buy) | I | 248 672 | 248 672 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Common Stock | I | 15,0000 | 133 333 | 2 000 | 4 721 449 | ||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Common Stock | I | 1 013 547 | 4 588 116 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Common Stock | I | 2 579 881 | 3 574 569 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Forbion Capital Fund III Cooperatief U.A. | REPL | Common Stock | I | 994 688 | 994 688 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | SLATTERY JOSEPH P | REPL | Stock Option (right to buy) | D | 15,00 | 13 500 | 13 500 | |||||
| 2018-07-26 | 2018-07-24 | 4 | SLATTERY JOSEPH P | REPL | Common Stock | D | 15,0000 | 6 667 | 100 | 6 667 | ||||
| 2018-07-26 | 2018-07-24 | 4 | Coffin Robert | REPL | Employee Stock Option (right to buy) | D | 15,00 | 175 000 | 175 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Rhodes Jason P | REPL | Stock Option (right to buy) | D | 15,00 | 13 500 | 13 500 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Rhodes Jason P | REPL | Series B Convertible Preferred Stock | I | −1 013 547 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Rhodes Jason P | REPL | Series A Convertible Preferred Stock | I | −3 439 839 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Rhodes Jason P | REPL | Common Stock | I | 1 013 547 | 4 453 386 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Rhodes Jason P | REPL | Common Stock | I | 3 439 839 | 3 439 839 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Love Colin | REPL | Employee Stock Option (right to buy) | D | 15,00 | 100 000 | 100 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | GORGOL STEPHEN A | REPL | Employee Stock Option (right to buy) | D | 15,00 | 35 000 | 35 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Esposito Pamela | REPL | Employee Stock Option (right to buy) | D | 15,00 | 70 000 | 70 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Levitsky Hyam | REPL | Stock Option (right to buy) | D | 15,00 | 27 000 | 27 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Kaufman Howard | REPL | Employee Stock Option (right to buy) | D | 15,00 | 150 000 | 150 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Weinand Dieter | REPL | Stock Option (right to buy) | D | 15,00 | 27 000 | 27 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Atlas Venture Fund X, L.P. | REPL | Series B Convertible Preferred Stock | D | −1 013 547 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Atlas Venture Fund X, L.P. | REPL | Series A Convertible Preferred Stock | D | −3 439 839 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | 1 013 547 | 4 453 386 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Atlas Venture Fund X, L.P. | REPL | Common Stock | D | 3 439 839 | 3 439 839 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Dhingra Kapil | REPL | Stock Option (right to buy) | D | 15,00 | 13 500 | 13 500 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Astley-Sparke Philip | REPL | Employee Stock Option (right to buy) | D | 15,00 | 140 000 | 140 000 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Stock Option (right to buy) | D | 15,00 | 13 500 | 13 500 | |||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Series B Convertible Preferred Stock | I | −1 013 547 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Series A Convertible Preferred Stock | I | −2 579 881 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Series Seed Convertible Preferred Stock | I | −994 688 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Warrant (right to buy) | I | −248 672 | 0 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Warrant (right to buy) | I | 248 672 | 248 672 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Common Stock | I | 15,0000 | 133 333 | 2 000 | 4 721 449 | ||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Common Stock | I | 1 013 547 | 4 588 116 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Common Stock | I | 2 579 881 | 3 574 569 | ||||||
| 2018-07-26 | 2018-07-24 | 4 | Slootweg Hugo Alexander | REPL | Common Stock | I | 994 688 | 994 688 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Series B Convertible Preferred Stock | D | −101 896 | 0 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Series A Convertible Preferred Stock | D | −259 366 | 0 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Series Seed Preferred Stock | D | −100 000 | 0 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Common Stock Warrants (right to buy) | D | 248 672 | 248 672 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Series Seed Warrants (right to buy) | D | −25 000 | 0 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 1 013 547 | 4 854 783 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 2 579 881 | 3 841 236 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 994 688 | 1 261 355 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Omega Fund IV, L.P. | REPL | Common Stock | D | 15,0000 | 266 667 | 4 000 | 266 667 | ||||
| 2018-07-25 | 2018-07-19 | 4 | Omega Fund IV, L.P. | REPL | Common Stock Option | D | 15,00 | 13 500 | 13 500 | |||||
| 2018-07-25 | 2018-07-24 | 4 | Redmile Group, LLC | REPL | Series B Convertible Preferred Stock | I | −78 382 | 0 | ||||||
| 2018-07-25 | 2018-07-24 | 4 | Redmile Group, LLC | REPL | Common Stock | I | 779 655 | 779 655 | ||||||
| 2018-07-19 | 3 | Astley-Sparke Philip | REPL | Common Stock | D | 2 884 594 | ||||||||
| 2018-07-19 | 3 | Astley-Sparke Philip | REPL | Common Stock | D | 2 884 594 | ||||||||
| 2018-07-19 | 3 | Astley-Sparke Philip | REPL | Common Stock | D | 2 884 594 | ||||||||
| 2018-07-19 | 3 | Coffin Robert | REPL | Common Stock | D | 4 824 236 | ||||||||
| 2018-07-19 | 3 | Coffin Robert | REPL | Common Stock | D | 4 824 236 | ||||||||
| 2018-07-19 | 3 | Coffin Robert | REPL | Common Stock | D | 4 824 236 | ||||||||
| 2018-07-19 | 3 | Love Colin | REPL | Common Stock | D | 2 238 048 | ||||||||
| 2018-07-19 | 3 | Love Colin | REPL | Common Stock | D | 2 238 048 | ||||||||
| 2018-07-19 | 3 | Love Colin | REPL | Common Stock | D | 2 238 048 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
